Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Harris Search Associates. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Harris Search Associates or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Assessing the State of Cancer Research: Insights from an Innovative Clinician-Scientist

47:03
 
Share
 

Manage episode 321046585 series 1526434
Content provided by Harris Search Associates. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Harris Search Associates or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Dr. Raymond Bergan, Deputy Director at the University of Nebraska Medical Center Fred and Pamela Buffet Cancer Center and Professor in both UNMC’s Eppley Institute for Research in Cancer and the Division of Oncology and Hematology in the Department of Internal Medicine, joins Innovators to share his assessment of the state of cancer research and what may be reasonably expected within the near future. Dr. Bergan began his career at Northwestern University where he served as Director of Experimental Therapeutics and Leader of the Prevention Program for the University’s Lurie Comprehensive Cancer Center. In addition to breakthrough work on early-phase cancer chemo-prevention, he demonstrated a new way for measuring prevention therapy in the individual cancer patient, important steps toward precision medicine and personalized therapy. In 2015, Dr. Bergan was recruited to join the Oregon Health & Science University as Head of hematology and oncology and as Associate Director of medical oncology for the Knight Cancer Institute at OHSU. There too he led work that enabled individualized patient treatment with greater precision of effectiveness in ways that can change how cancer is treated henceforth.

In late 2020, Dr. Bergan joined the University of Nebraska Medical Center.

His undergraduate degree is from the State University of New York at Buffalo and he earned the M.D. from the SUNY Health Science Center at Syracuse, where he also completed his internship and residency. He was awarded two fellowships in the National Cancer Institute of the National Institutes of Health.

Innovators is a podcast production of Harris Search Associates.

*The views and opinions shared by the guests on Innovators do not necessarily reflect the views of the interviewee's institution or organization.*

  continue reading

72 episodes

Artwork
iconShare
 
Manage episode 321046585 series 1526434
Content provided by Harris Search Associates. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Harris Search Associates or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Dr. Raymond Bergan, Deputy Director at the University of Nebraska Medical Center Fred and Pamela Buffet Cancer Center and Professor in both UNMC’s Eppley Institute for Research in Cancer and the Division of Oncology and Hematology in the Department of Internal Medicine, joins Innovators to share his assessment of the state of cancer research and what may be reasonably expected within the near future. Dr. Bergan began his career at Northwestern University where he served as Director of Experimental Therapeutics and Leader of the Prevention Program for the University’s Lurie Comprehensive Cancer Center. In addition to breakthrough work on early-phase cancer chemo-prevention, he demonstrated a new way for measuring prevention therapy in the individual cancer patient, important steps toward precision medicine and personalized therapy. In 2015, Dr. Bergan was recruited to join the Oregon Health & Science University as Head of hematology and oncology and as Associate Director of medical oncology for the Knight Cancer Institute at OHSU. There too he led work that enabled individualized patient treatment with greater precision of effectiveness in ways that can change how cancer is treated henceforth.

In late 2020, Dr. Bergan joined the University of Nebraska Medical Center.

His undergraduate degree is from the State University of New York at Buffalo and he earned the M.D. from the SUNY Health Science Center at Syracuse, where he also completed his internship and residency. He was awarded two fellowships in the National Cancer Institute of the National Institutes of Health.

Innovators is a podcast production of Harris Search Associates.

*The views and opinions shared by the guests on Innovators do not necessarily reflect the views of the interviewee's institution or organization.*

  continue reading

72 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play